Treatment for patients hospitalized with COVID-19 is continuously evolving. Some medications have proven beneficial over the past year, while others have fallen out of favor. Here we review the most recent guidelines as of August 2021. In short, it is...
Community-acquired pneumonia (CAP) is defined as pneumonia acquired outside of hospitals, (less than 48 hours from hospital admission). Patients will typically present with symptoms including fever, chills, chest pain, cough, sputum production, and dyspnea. Objective...
Proton Pump Inhibitors (PPIs) are a well-known staple in the management of upper GI bleeds (UGIB). Recently, there was a question regarding the efficacy and appropriateness of PPI use in lower GI bleeds (LGIB). First, let’s evaluate some common characteristics used to...
Excess calcium levels can be life-threatening if they become severely elevated (>14 mg/dL), causing symptoms such as polyuria and polydipsia due to nephrogenic diabetes insipidus, nephrolithiasis, bone pain, nausea, vomiting, anorexia, confusion, rare cardiac...
In this article, I wanted to share information on tapering clonidine. This drug can cause serious rebound hypertension when abruptly discontinued and patients may not understand or realize that this risk exists. Here’s a case scenario that demonstrates tapering...
